Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
The health and economic impact of Ontario's Grade 8 HPV vaccination program
FY 2010-11
Summary
Every year, the Ontario government invests about $39 million in a program that offers the human papillomavirus (HPV) vaccine to all Grade 8 girls in the province. However, almost 50% of eligible girls are refusing to get vaccinated. This poor acceptance has been largely attributed to concerns among parents who feel there is not yet enough information about the real world effects of this vaccine. At the same time, such low uptake threatens public health efforts aimed making the costly initiative worthwhile. The objectives of this thesis are to assess the vaccine's effect on the incidence of genital warts and uptake of Pap screening, and to evaluate the real world cost-effectiveness of Ontario's program.
This study is based on all girls eligible for Ontario's Grade 8 HPV vaccination program between 2007 and 2011. Information on the girls' HPV vaccine use and medical history will be obtained from Ontario administrative health databases. This information will be used to determine if the risk of developing genital warts differs between girls who get the vaccine and girls who do not. In addition, it will be used to determine whether Pap screening, an established mean of preventing cervical cancer, is affected by HPV vaccination. Finally, to determine the economic value of Ontario's HPV vaccination program, a cost-effectiveness analysis will be performed based on the program's first five years of implementation.
In efforts to maximize the health benefits and cost-effectiveness of Ontario's publicly funded HPV vaccination program, it is important that its effects are monitored and evaluated. The results of this study will provide information about the real world effects of the HPV vaccine that could help individuals make more educated decisions about vaccination. In addition, the results can assist public health decision-makers in making informed policy recommendations about ways to improve future HPV vaccine programming.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
229614
Name
Smith Leah M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
The health and economic impact of Ontario's Grade 8 HPV vaccination program
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cohort Study; Cost-Effectiveness; Hpv Vaccine; Pharmacoepidemiology; Population And Public Health
Abstract
Every year, the Ontario government invests about $39 million in a program that offers the human papillomavirus (HPV) vaccine to all Grade 8 girls in the province. However, almost 50% of eligible girls are refusing to get vaccinated. This poor acceptance has been largely attributed to concerns among parents who feel there is not yet enough information about the real world effects of this vaccine. At the same time, such low uptake threatens public health efforts aimed making the costly initiative worthwhile. The objectives of this thesis are to assess the vaccine's effect on the incidence of genital warts and uptake of Pap screening, and to evaluate the real world cost-effectiveness of Ontario's program.
This study is based on all girls eligible for Ontario's Grade 8 HPV vaccination program between 2007 and 2011. Information on the girls' HPV vaccine use and medical history will be obtained from Ontario administrative health databases. This information will be used to determine if the risk of developing genital warts differs between girls who get the vaccine and girls who do not. In addition, it will be used to determine whether Pap screening, an established mean of preventing cervical cancer, is affected by HPV vaccination. Finally, to determine the economic value of Ontario's HPV vaccination program, a cost-effectiveness analysis will be performed based on the program's first five years of implementation.
In efforts to maximize the health benefits and cost-effectiveness of Ontario's publicly funded HPV vaccination program, it is important that its effects are monitored and evaluated. The results of this study will provide information about the real world effects of the HPV vaccine that could help individuals make more educated decisions about vaccination. In addition, the results can assist public health decision-makers in making informed policy recommendations about ways to improve future HPV vaccine programming.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Smith, Leah M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~